Quick Takeaways
- This page summarizes Eric Venker's Form 4 filing for Roivant Sciences Ltd. (ROIV).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 22 Nov 2022, 17:30.
Eric Venker - 20 Nov 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)
- Role
- President & COO
- Signature
- By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
- Issuer symbol
- ROIV
- Transactions as of
- 20 Nov 2022
- Net transactions value
- -$80,015
- Form type
- 4
- Filing time
- 22 Nov 2022, 17:30:55 UTC
- Previous filing
- 27 Oct 2022
- Next filing
- 09 Dec 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Eric Venker filed Form 4 for Roivant Sciences Ltd. (ROIV) on 22 Nov 2022."
What Changed
- Previous filing in this sequence was filed on 27 Oct 2022.
- Current net transaction value: -$80,015.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ROIV | Common Shares | Other | $80,015 | -16,003 | -1.5% | $5.00 | 1,033,847 | 20 Nov 2022 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |